TOP TIERMARKET NEWSWIRE
News & sentiment

LEXEO THERAPEUTICS I (LXEO) — News & AI sentiment

LEXEO THERAPEUTICS I (LXEO) news roundup. 3 stories in the past week, 8 over 30 days. Average 30-day sentiment is 53/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $43K — net selling of $43K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 54.7/100
30d stories
8
avg sentiment 53/100
Insider net (90d)
$43K
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

LXEO news in the last 24 hours, 7 days, 30 days and 90 days

How much LXEO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowLXEO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days354.7/100LXEO headlines →
Last 30 days853/100LXEO headlines →
Last 90 days3156.4/100LXEO headlines →

Latest stories on LXEO

Oppenheimer reiterates Lexeo Therapeutics stock rating on trial data
Investing.com Analyst Ratings52 · neutralanalyst
4d ago
4d ago
4d ago
Oct 24
Oct 21
Oct 19
Oct 8
Oct 8
Stifel reiterates Buy rating on Lexeo Therapeutics stock at $17
Investing.com Analyst Ratings61 · neutralanalyst
Oct 5
Oct 1
Oct 1
Sep 29
Sep 23
Sep 23
Sep 23
Sep 22
Sep 22
Baird reiterates Lexeo Therapeutics stock rating on acquisition deal
Investing.com Analyst Ratings56 · neutralanalyst
Sep 22
Why is Lexeo Therapeutics stock gaining today?
Investing.com Markets55 · neutralgeneral
Sep 22
Sep 22
Sep 22
Sep 22
Sep 22
Sep 22
Sep 2
Open LXEO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →